Deep Longevity

Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging.

Deep Longevity operates in health based in Tokyo, Japan.

Profile

Deep Longevity is a biotechnology company advancing longevity research and development through AI-discovered biomarkers of aging. By integrating diverse data types—including clinical blood tests, transcriptomic, proteomic, epigenetic, microbiome, behavioral, wearable, and imaging data—Deep Longevity offers multifactorial aging clocks that measure biological age with precision. The company provides aging and longevity solutions to clinics, preventative medicine organizations, health clubs, insurance companies, and research institutions. Key offerings include the Longevity Cloud, which hosts aging clocks, recommendation engines, and longevity databases; AI-driven recommendation engines for personalized longevity interventions; and AgeMetric Reports, a comprehensive system for tracking biological age. Deep Longevity’s platforms, including Young.AI and API access, enable accessible and interpretable biological age predictions. By pioneering AI-based biomarkers and integrative aging metrics, Deep Longevity contributes significantly to innovation in longevity science and personalized health management.

As a business in health, Deep Longevity is listed here with the public details available about it.

Its base of operations is Tokyo, Japan.

The company is listed at the Plug and Play accelerated startup stage of development.

Website: deeplongevity.com